Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03070535 · ClinicalTrials.gov registry record · NA
APOE Genotype and Diet Influences on Alzheimer's Biomarkers
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 78
- Enrollment target
NCT03070535: Completed NA study, sponsored by University of Washington.
NCT03070535 is a NA study that has completed, run by University of Washington. The registered enrollment target is 78 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03070535, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 78 participants
- Enrollment target
Study Summary
This study involves the collection of cognitive and biomarker responses to HIGH and LOW meals in healthy older adults with and without the APOE E4 genotype. Subjects will eat the meal after an overnight fast, followed by cognitive testing, spinal fluid and blood collection. The HIGH meal will be a meal high in saturated fat and high glycemic index foods vs. LOW meal which will be low in saturated fat and low glycemic index foods.
Primary Outcome
Paired serum and cerebrospinal fluid levels of free fatty acids and triglycerides
Interventions
- OTHER HIGH and LOW meal ingestion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2016-09 |
| Est. Completion | 2023-03-30 |
| Phase | NA |
What the finished NCT03070535 record still lists
NCT03070535 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 78 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which HIGH and LOW meal ingestion is the first listed.
NCT03070535 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03070535 about?
NCT03070535 is a clinical study titled "APOE Genotype and Diet Influences on Alzheimer's Biomarkers". This study involves the collection of cognitive and biomarker responses to HIGH and LOW meals in healthy older adults with and without the APOE E4 genotype. Subjects will eat the meal after an overnight fast, followed by cognitive testing, spinal fluid and blood collection. The HIGH meal will be a m...
What is the current status of trial NCT03070535?
This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2016-09. Estimated completion is 2023-03-30.
What interventions are being tested in trial NCT03070535?
The interventions under investigation include: HIGH and LOW meal ingestion (OTHER).
Who is sponsoring clinical trial NCT03070535?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03070535's enrollment target sits among peer trials
78 1060th of 2000 higher than 939 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02397668 · 78 participants · NA
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
- NCT03321656 · 78 participants · Phase 2
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
- NCT03687814 · 78 participants · NA
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
- NCT04018872 · 78 participants · Phase 2
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia